Luis F. Quintana is Head of the Clinical Nephrology Section in the Nephrology and Kidney Transplant Department at Hospital Clínic de Barcelona. This section is a member of the European Reference Network for Rare Kidney Diseases (ERKNET) and is endorsed by the Spanish national health system as a Reference Center for Complex Glomerular Diseases (CSUR) and by the Catalan health system as a reference center for rare kidney diseases. Dr. Quintana is a renowned researcher at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Full Professor in the Department of Medicine at the University of Barcelona, where he coordinates the kidney disease course in the Master's Degree in Autoimmune Diseases. He is also the coordinator of the Nephropathology Committee at Hospital Clínic de Barcelona, together with Dr. Adriana García-Herrera, Head of Section in the Pathology Department. He is also currently a member of the board of the Immuno-Nephrology Working Group of the European Renal Association (ERA) and the coordinator of the Catalan group on diseases (GLOMCAT). Dr. Quintana specialized in Internal Medicine at the Universidad Colegio Mayor de Nuestra Señora del Rosario (Bogotá, Colombia). Between 2001 and 2005, he specialized in Nephrology at the Hospital Clínic de Barcelona and in 2009, he obtained his doctorate and extraordinary doctoral award from the University of Barcelona for his thesis on the role of urinary proteomics in chronic graft dysfunction. His postdoctoral experience includes a two-year stay at the Lupus and Vasculitis Clinic of the Department of Medicine at the University of Cambridge (UK). Dr. Quintana is the PI of the active project PI23/00569-PI049323 Identifying the map of progression to chronic kidney disease in glomerular pathology, funded by the Carlos III Health Institute. He is also head of the nephrology group (Hospital Clinic) of the 3TR research project (Innovative Medicines Initiative (IMI) European Union), currently in the recruitment phase, and PI of the project Phenotypic and functional characterization of lymphocytes, monocytes and macrophages by flow cytometry of urinary sediment in patients with lupus nephritis for the prediction of chronic kidney disease, funded by the Spanish Society of Nephrology. He has also been PI of the projects 'Role of Digital Pathology and Magnetic Nuclear Resonance in the early detection of fibrosis in chronic kidney disease' (PI17/00080) funded by the Carlos III Health Institute and of the research project funded by the La Marató Foundation 'Generation of stem cells with induced pluripotency from patients with genetic diseases with kidney damage: Correction and modeling of kidney diseases in vitro'. He is currently PI of 12 active clinical trials in glomerular diseases and in the last 10 years has participated in 40 clinical trials in this same field. He has given more than 150 invited lectures and published more than 120 scientific articles (h-index: 30), including 60 original studies in top-tier journals in his field, 6 consensus documents and reference clinical practice guidelines (in Spain and Latin America) in the field of lupus nephritis and the renal adverse effects of cancer immunotherapy, and 3 patent applications. He has been a lecturer on the Master's Degree in Advanced Skills in Autoimmune Diseases since 2010 and coordinator of the Nephrology subject of this Master's Degree since 2015.